About GalenusRx
GalenusRx is a company based in Fernandina Beach (United States) founded in 2023 by Veronique Michaud, Orsula V Knowlton, Jacques Turgeon, and Calvin H Knowlton. GalenusRx has raised $6.88 million across 1 funding round. GalenusRx offers products and services including APPRAISE Platform and Lifesaving Insights. GalenusRx operates in a competitive market with competitors including House Rx, DecisionRx, Eurekam, Prescription Advisory Systems & Technology and Pillcheck, among others.
- Headquarter Fernandina Beach, United States
- Founders Veronique Michaud, Orsula V Knowlton, Jacques Turgeon, Calvin H Knowlton
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Galenusrx, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6.88 M (USD)
in 1 rounds
-
Latest Funding Round
$6.88 M (USD), Series A
Aug 30, 2023
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GalenusRx
GalenusRx offers a comprehensive portfolio of products and services, including APPRAISE Platform and Lifesaving Insights.
Analyzes drug interactions for personalized risk assessments.
Provides subscription-based medication response analysis and recommendations.
Funding Insights of GalenusRx
GalenusRx has successfully raised a total of $6.88M through 1 strategic funding round. The most recent funding activity was a Series A round of $6.88 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by GalenusRx
Investment portfolio details for GalenusRx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GalenusRx
Detailed financials for GalenusRx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Galenusrx Comparisons
Peer comparison for GalenusRx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GalenusRx
GalenusRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as House Rx, DecisionRx, Eurekam, Prescription Advisory Systems & Technology and Pillcheck, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology-based medication solutions are provided for patients and caregivers.
|
|
| Locked | Locked | Locked |
Medication management solutions are provided to patients and healthcare providers.
|
|
| Locked | Locked | Locked |
AI-based medication management solutions for oncology professionals are provided.
|
|
| Locked | Locked | Locked |
Software for Doctors to Help Treat Pain & Reduce Abuse of Controlled Substances
|
|
| Locked | Locked | Locked |
DNA testing platform for user medication responses is offered.
|
Detailed competitors of GalenusRx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Galenusrx
Complete news archive for GalenusRx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GalenusRx
GalenusRx was founded in 2023.
GalenusRx is headquartered in Fernandina Beach, United States. It is registered at Fernandina Beach, Florida, United States.
Jacques Turgeon is the current CEO of GalenusRx. They have also founded this company.
GalenusRx is a funded company, having raised a total of $6.88M across 1 funding round to date.
Founded in 2023, GalenusRx operates in the healthcare sector from Fernandina Beach, United States. A web-based solution is offered to assist clinicians in managing medications for patients with polypharmacy. Risk management tools are focused on enhancing medication safety within healthcare organizations. Operations emphasize real-world applications suited to complex patient needs.
GalenusRx's top competitors include House Rx, DecisionRx and Eurekam.
GalenusRx offers APPRAISE Platform and Lifesaving Insights.